TSX : EPRX.TO

Eupraxia Pharmaceuticals Inc. — Competitors

$8.86 CAD

-$0.24 (-2.64%)

Volume
32.86K
Average Volume
63.22K
Market Capitalization
$318.41M
P/E Ratio
-6.00
Dividend Yield
0.00%
Price Target
Year High
$12.86
Year Low
$6.94
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$19.30
EPRX.TO vs. The Competition
Properties EPRX.TO CYBN.NE DR.TO FRX.TO
Market Cap $318.41M $265.3M $314.15M $430.39M
Shares Outstanding $35.94M $24.21M $17.55M $30.27M
P/E Ratio -6.0 -1.89 8.89 -33.05
EPS -0.78 -2.92 2.42 -0.24
Day Low 8.75 10.81 17.9 14.22
Day High 9.12 11.45 18.02 14.22
Year Low 6.94 5.3 13.59 7.59
Year High 12.86 15.27 18.79 15.48
Average Price 50 9.2172 9.2786 17.859 13.3084
Average Price 200 9.7264 9.6008 16.39965 11.33905
Volume 32857 6690 4834 2
Average Volume - - - -
EPRX.TO Top Competitors
Symbol Name Last Change %Chg Volume
CYBN.NE Cybin Inc. $10.96 -0.08 -0.72% 6690
DR.TO Medical Facilities Corporation $17.9 -0.03 -0.17% 4834
FRX.TO Fennec Pharmaceuticals Inc. $14.22 0 0.00% 2